Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by HomerAndCompanyon Apr 06, 2022 9:27am
200 Views
Post# 34579945

RE:RE:Still Early

RE:RE:Still Early
Johnandrose22 wrote: Just a word of appreciation to those on the board who are discerning the clinical data, to date. As a layman in this specific discipline I appreciate the honest discernment going on throughout the day.

I would be dishonest if I said I was not disappointed by the current data set. I did expect more. That being said, I remain steadfast in my investment.

What jolted me the most, I suppose, was the relatively muted and unenthusiastic reflections from Dr. Vera and Dr. Mandel in summary. Surprisingly, at least to me, there was no longer mention of BTD or future Gold Standard language mentioned in their summations. They almost seem a bit disappointed themselves. Be assured, this is not an indictment but simply a personal interpretation.

I will support this company via my investment until the end...of them or me.

I remain hopeful.

John



Should we read anything negative into the data beyond that it's still early and much of the data is simply not yet in? Clearly the market thinks so, or thought so yesterday. Today will be interesting!

Did doctors Vera & Mandel have reason to mute their earlier enthusiastic language? Or was that just a coincidence that it coincided with the releae of somewhat cryptic data - which itself is just business as usual with their releases?   

<< Previous
Bullboard Posts
Next >>